Life-threatening Mast Cell Activation and Anaphylaxis in Mast Cell Leukemia and the Role of Omalizumab

被引：0
|
作者：
Hammond, T. C. [1 ]
Emeruwa, I. [1 ]
Swain, S. R. [2 ]
Larson, S. M. [3 ]
Castells, M. C. [4 ]
机构：
[1] UCLA, Pulmonary Crit Care Sleep Med, Santa Monica, CA USA
[2] UCLA, Allergy & Immunol, Santa Monica, CA USA
[3] UCLA, Hematol Oncol, Los Angeles, CA USA
[4] Brigham & Womens Hosp, Allergy & Immunol, Boston, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5294
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Omalizumab and Mast Cell Disorders: Are We There Yet?
    Weiler, Catherine R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (07): : 2396 - 2397
  • [42] Omalizumab: Efficacy and Safety in Mast Cell Disorders
    Lemal, Richard
    Fouquet, Guillemette
    Terriou, Louis
    Vaes, Melanie
    Livideanu, Cristina
    Frenzel, Laurent
    Barete, Stephane
    Canioni, Danielle
    Lhermitte, Ludovic
    Bay, Jacques-Olivier
    Rossignol, Julien
    Arock, Michel
    Lortholary, Olivier
    Hermine, Olivier
    BLOOD, 2018, 132
  • [43] Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review
    Sabato, Vito
    Michel, Moise
    Blank, Ulrich
    Ebo, Didier G.
    Vitte, Joana
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 21 (05) : 426 - 434
  • [44] Recurrent uncommon presentation of anaphylaxis in a patient with mast cell activation syndrome
    Courcol, J.
    Dissanayake, G.
    Ncomanzi, D.
    ANAESTHESIA, 2021, 76 : 114 - 114
  • [45] SCITING TO A HALT: A CASE OF MAST CELL ACTIVATION SYNDROME AND RECURRENT ANAPHYLAXIS
    Ariza, J.
    Gada, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S111 - S111
  • [46] Successful adjuvant use of omalizumab in life-threatening bee-venom anaphylaxis
    Gonzalez-Perez, R.
    Poza-Guedes, P.
    Matheu-Delgado, V
    Sanchez-Machin, I
    Martinez-Tadeo, J.
    Rodriguez-Plata, E.
    ALLERGY, 2010, 65 : 651 - 651
  • [47] Novel role of transmembrane SCP for mast cell activation and eotaxin production in mast cell fibroblast interactions
    Hogaboam, G
    Kunkel, SL
    Strieter, RM
    Taub, DD
    Lincoln, P
    Standiford, TJ
    Lukacs, NW
    JOURNAL OF IMMUNOLOGY, 1998, 160 (12): : 6166 - 6171
  • [48] Unaltered mast cell reactivity in patients with mast cell activation disorders
    Gulen, T.
    Westerberg, Moeller C.
    Kolmert, J.
    Larsson, J.
    Dahlen, S-E
    Dahlen, B.
    Nilsson, G.
    ALLERGY, 2014, 69 : 13 - 13
  • [49] Mast Cell-Targeting Therapies in Mast Cell Activation Syndromes
    Sabato, Vito
    Beyens, Michiel
    Toscano, Alessandro
    Van Gasse, Athina
    Ebo, Didier G.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2024, 24 (02) : 63 - 71
  • [50] Pharmacotherapy in Mast Cell Leukemia
    Laforgia, Mariarita
    Calabro, Concetta
    Scattone, Anna
    Laface, Carmelo
    Porcelli, Mariangela
    Gadaleta, Cosmo Damiano
    Nardulli, Patrizia
    Ranieri, Girolamo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (09) : 1059 - 1069
12345